ストックスクリーナーアプリを入手
114.27
9.82%
10.38
Insmed Inc (INSM) 最新ニュース
[144] INSMED Inc SEC Filing - Stock Titan
Zoetis, Insmed, and HubSpot are among top 10 large-cap losers last week (May 4-May 8): Are the others in your portfolio? - MSN
INSM Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
A Quick Look at Today's Ratings for Insmed(INSM.US), With a Forecast Between $160 to $237 - Moomoo
Insmed Incorporated (NASDAQ:INSM) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year - Moomoo
Here's What Analysts Are Forecasting For Insmed Incorporated (NASDAQ:INSM) After Its First-Quarter Results - Yahoo Finance
Insmed (INSM) Q1 2026 Revenue Surge Tests Profitability Narrative - simplywall.st
Insmed (INSM) Post-Earnings Selloff Seen as Buying Opportunity - GuruFocus
INSM Maintained by RBC Capital -- Price Target Lowered to $205 - GuruFocus
INSM Maintained by Wells Fargo -- Price Target Lowered to $160 - GuruFocus
Insmed Stock Sell-off Is Overdone as Underlying Metrics Appear Positive, RBC Says - Moomoo
RBC Cuts Price Target on Insmed to $205 From $220, Keeps Outperform Rating - Moomoo
Insmed Stock Sell-off is Overdone as Underlying Metrics Appear Positive, RBC Says - marketscreener.com
Insmed's Q1 earnings beat, sales miss estimates, stock tanks 23% - MSN
INSM Maintains by Guggenheim -- Price Target Lowered to $226 - GuruFocus
A Quick Look at Today's Ratings for Insmed(INSM.US), With a Forecast Between $160 to $243 - Moomoo
Insmed's Q1 Earnings Beat, Sales Miss Estimates, Stock Tanks 23% - TradingView
Insmed’s 44% decline validates InvestingPro’s overvalued call By Investing.com - Investing.com
INSM Stock Price, Quote & Chart | INSMED INC (NASDAQ:INSM) - ChartMill
Insmed Q1 2026 slides: BRINSUPRI surges 44%, ARIKAYCE expansion ahead By Investing.com - Investing.com South Africa
Insmed Q1 Earnings Call Highlights - Yahoo Finance
TD Cowen Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $243 - Moomoo
Insmed Earnings Call Highlights BRINSUPRI-Driven Momentum - TipRanks
Insmed's Blockbuster Drug Brinsupri Drives Record Revenue, Yet Shares Tumble - AD HOC NEWS
Insmed (INSM) Q1 2026 Earnings Transcript - The Globe and Mail
Roth MKM Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $212 - Moomoo
Insmed Incorporated Q1 2026 Earnings Call Summary - Yahoo Finance
Insmed Bronchiectasis Push With Ty Pennington May Expand Therapy Opportunity - simplywall.st
U.S. Indexes Closed Down Thursday; Insmed Fell Furthest - Barron's
Insmed reiterates BRINSUPRI at least $1B 2026 revenue target while targeting ARIKAYCE label expansion in H1 2027 - MSN
Insmed Tanks On Its Most Important Launch; Why Analysts Remain Bullish - Investor's Business Daily
Insmed Down Over 21%, Worst Performer in the Nasdaq 100 So Far Today -- Data Talk - Moomoo
Insmed Q1 2026 slides: BRINSUPRI surges 44%, ARIKAYCE expansion ahead - Investing.com
Earnings call transcript: Insmed Q1 2026 beats forecasts but stock tumbles - Investing.com
Nasdaq 100 Climbs Records, Oil Extends Drop As Iran Weighs Hormuz Deal: Stock Market Today - Benzinga
Earnings call transcript: Insmed Q1 2026 beats forecasts but stock tumbles By Investing.com - Investing.com South Africa
William Blair Maintains Insmed(INSM.US) With Buy Rating - Moomoo
IBD: Insmed Tanks On Its Most Important Launch; Why Analysts Remain Bullish - Moomoo
INSM: BRINSUPRI's launch outperformed expectations, driving strong revenue and sustained growth - TradingView
Why is Insmed stock sliding today? - Investing.com
Why is Insmed stock sliding today? By Investing.com - Investing.com Canada
Insmed Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Insmed Inc Stock Warning Signs - GuruFocus
Insmed Q1 Loss Narrows, Revenue Rises; Shares Down Pre-Bell - Moomoo
Insmed reports new cathepsin C inhibitors - BioWorld News
Insmed (INSM) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Insmed (NASDAQ:INSM) Q1 Revenue Miss Triggers Pre-Market Slide Despite Narrower Loss - ChartMill
Insmed stock falls 6% on Q1 beat as investors eye guidance By Investing.com - Investing.com UK
Q1 2026 Insmed Inc Earnings Call Transcript - GuruFocus
Earnings Flash (INSM) Insmed Incorporated Reports Q1 Revenue $306.0M, vs. FactSet Est of $300.8M - marketscreener.com
Earnings Flash (INSM) Insmed Posts Q1 Net Product Revenue $306M, vs. FactSet Est of $300.8M - marketscreener.com
Earnings Flash (INSM) Insmed Posts Q1 Loss $0.76 a Share, vs. FactSet Est of $0.96 Loss - marketscreener.com
INSMED ($INSM) Releases Q1 2026 Earnings - Quiver Quantitative
Insmed: Q1 Earnings Snapshot - marketscreener.com
Insmed Q1 revenue jumps 230%, net loss narrows - TradingView
INSMED Inc 1Q 2026: Revenue $306M, EPS $(0.76) — 10-Q Summary - TradingView
0.34%
1.01%
大文字化:
|
ボリューム (24 時間):